RxDoctor Payments Data

David Foreman, MD

Otolaryngology · Lafayette, LANPI 1730158320

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 34.7% of the total. 2025 is the largest year on record at $1,282, 2.0 times the $632 reported in 2019.

$5,454in general payments, 2019–2025

Across 289 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Optinose US, Inc.$1K
  • Axsome Therapeutics, Inc.$452
  • Sanofi$415
  • Hikma Pharmaceuticals USA$304
  • GSK$205
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$5,42099%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,454 in reported general payments places this provider in the 85th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$375,176
Medicare patients
867
Services billed
9,045

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab14$54,573
Modafinil52$6,440
Azelastine Hcl134$2,941
Fluticasone Propionate192$2,247
Omeprazole178$2,010
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$1,890
Esomeprazole Magnesium64$1,776
Famotidine156$1,380
Mupirocin150$843
Fluocinolone Acetonide Oil18$750
Ondansetron OdtOndansetron145$745
Ciprofloxacin Hcl94$485
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$403
Gabapentin55$339
Albuterol Sulfate HfaAlbuterol Sulfate14$299

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →